Age group of the respondents |
|
25–35 yo |
5 (7.5) |
35–45 yo |
26 (39.4) |
45–55 yo |
21 (31.8) |
> 55 yo |
14 (21.2) |
Epilepsy clinic |
|
Monographic epilepsy clinic |
53 (80.3) |
No monographic epilepsy clinic |
13 (19.7) |
Direct care to patients with COVID-19 in addition to their neurology tasks |
|
Yes |
25 (37.9) |
No |
41 (62.1) |
Number of patients with epilepsy attended per week |
|
< 10 |
4 (6.1) |
10 to 20 patients |
23 (34.8) |
> 20 patients |
39 (59) |
|
Video-EEG available as a diagnostic tool in their facilities |
56 (84.4) |
Changes in antiseizure medications (type or dose) during visits |
|
Less frequently than during onsite visits |
42(63.6) |
Similar frequency to onsite visits |
24 (36.4) |
Duration of remote visits |
|
Shorter time than onsite visits |
37 (56.1) |
Similar time than onsite visits |
24 (36.4) |
Longer time than onsite visits |
5 (7.6) |
Administrative support to organize remote visits |
|
Support |
35 (53) |
Self-organization |
31 (47) |
Technical difficulties to communicate with the patients |
|
Sometimes |
22 (33.3) |
Frequently |
5 (7.6) |
Never |
6 (9.1) |
Rarely |
33 (50) |
Future teleneurology visits for patients with epilepsy |
|
Convinced to use in telemedicine |
22 (33.3) |
Open to telematic visits in the future |
34 (51.52) |
Preferred face-to-face visits |
6 (9.1) |